GC Biopharma Corp. (KRX:006280)
South Korea · Delayed Price · Currency is KRW 156,400
-1,900 (-1.20%)
At close: Jan 9, 2026
GC Biopharma Market Cap
GC Biopharma has a market cap or net worth of 1.79 trillion as of January 9, 2026. Its market cap has increased by 5.82% in one year.
Market Cap
1.79T
Enterprise Value
2.93T
Revenue
1.93T
Ranking
n/a
PE Ratio
31.69
Stock Price
156,400.00
Market Cap Chart
Since August 29, 1995, GC Biopharma's market cap has increased from 29.09B to 1.79T, an increase of 6,037.09%. That is a compound annual growth rate of 14.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 1.79T | -1.64% |
| Dec 30, 2025 | 1.81T | -11.42% |
| Dec 30, 2024 | 2.05T | 43.03% |
| Dec 28, 2023 | 1.43T | -3.09% |
| Dec 29, 2022 | 1.48T | -40.60% |
| Dec 30, 2021 | 2.49T | -46.31% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 87.26T |
| Celltrion | 46.60T |
| ALTEOGEN | 25.59T |
| ABL Bio | 11.88T |
| SK Biopharmaceuticals | 9.77T |
| Yuhan | 8.46T |
| LigaChem Biosciences | 6.71T |
| HLB Co., Ltd. | 6.71T |